Literature DB >> 24938018

Apolipoprotein B-48: a unique marker of chylomicron metabolism.

Katsuyuki Nakajima, Takeaki Nagamine, Masaki Q Fujita, Masumi Ai, Akira Tanaka, Ernst Schaefer.   

Abstract

Apolipoprotein B-48 (apoB-48) is known to be the only specific marker of intestinal chy lomicron particles. The amino acid sequence of apoB-48 represents 48% of the initial sequence of apoB-100. ApoB-48 is synthesized only by the intestine in humans, while apoB-100 is synthesized primarily by the liver. Therefore, apoB-48 is a most appropriate biomarker for cardiovascular and nutritional investigation of postprandial chylomicron metabolism. In this review article, we discussed the difference between the recent find ings and Zilversmit's proposal of postprandial hyperlipidemia reported over 30 years ago. The characteristics and role of apoB-48 as an apolipoprotein in chylomicrons, especially as a marker of chylomicron remnant lipoproteins, are described. The need for appropriate analytical methods to measure apoB-48 is also discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938018

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  15 in total

Review 1.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 2.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  Whey and Casein Proteins and Medium-Chain Saturated Fatty Acids from Milk Do Not Increase Low-Grade Inflammation in Abdominally Obese Adults.

Authors:  Mette Bohl; Ann Bjørnshave; Søren Gregersen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2016-03-14

Review 4.  Apolipoproteins in vascular biology and atherosclerotic disease.

Authors:  Anurag Mehta; Michael D Shapiro
Journal:  Nat Rev Cardiol       Date:  2021-10-08       Impact factor: 32.419

5.  Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction.

Authors:  Amir Bein; Cicely W Fadel; Ben Swenor; Wuji Cao; Rani K Powers; Diogo M Camacho; Arash Naziripour; Andrew Parsons; Nina LoGrande; Sanjay Sharma; Seongmin Kim; Sasan Jalili-Firoozinezhad; Jennifer Grant; David T Breault; Junaid Iqbal; Asad Ali; Lee A Denson; Sean R Moore; Rachelle Prantil-Baun; Girija Goyal; Donald E Ingber
Journal:  Nat Biomed Eng       Date:  2022-06-23       Impact factor: 29.234

Review 6.  Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.

Authors:  Alan Chait; Henry N Ginsberg; Tomas Vaisar; Jay W Heinecke; Ira J Goldberg; Karin E Bornfeldt
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

7.  Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial.

Authors:  Elin Rakvaag; Rasmus Fuglsang-Nielsen; Knud Erik Bach Knudsen; Rikard Landberg; Astrid Johannesson Hjelholt; Esben Søndergaard; Kjeld Hermansen; Søren Gregersen
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

8.  Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans.

Authors:  Cynthia L Bristow; Ronald Winston
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

9.  TANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons/VLDLs from the endoplasmic reticulum.

Authors:  António J M Santos; Cristina Nogueira; Maria Ortega-Bellido; Vivek Malhotra
Journal:  J Cell Biol       Date:  2016-05-02       Impact factor: 10.539

10.  Disentangling Host-Microbiota Regulation of Lipid Secretion by Enterocytes: Insights from Commensals Lactobacillus paracasei and Escherichia coli.

Authors:  Asmaa Tazi; João Ricardo Araujo; Céline Mulet; Ellen T Arena; Giulia Nigro; Thierry Pédron; Philippe J Sansonetti
Journal:  MBio       Date:  2018-09-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.